VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+34.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
553
New
Increased
Reduced
Closed

Top Buys

1
+$2.17M
2
+$2.09M
3
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

1
+$2.5M
2
+$2.43M
3
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
276
Regenxbio
RGNX
$327M
$276K 0.08%
19,181
+8,026
GPCR icon
277
Structure Therapeutics
GPCR
$2.81B
$276K 0.08%
3,967
-1,154
PCVX icon
278
Vaxcyte
PCVX
$7.6B
$276K 0.08%
5,979
+2,677
RCKT icon
279
Rocket Pharmaceuticals
RCKT
$366M
$275K 0.07%
78,474
+41,410
ZYME icon
280
Zymeworks
ZYME
$1.75B
$275K 0.07%
10,441
+1,755
ERAS icon
281
Erasca
ERAS
$3.12B
$275K 0.07%
73,896
-475
LQDA icon
282
Liquidia Corp
LQDA
$5.02B
$275K 0.07%
7,969
+95
JBIO
283
Jade Biosciences
JBIO
$1.12B
$274K 0.07%
+17,759
WVE icon
284
Wave Life Sciences
WVE
$1.31B
$273K 0.07%
16,064
+260
CMPS
285
Compass Pathways
CMPS
$1.39B
$272K 0.07%
39,471
+14,297
ABUS icon
286
Arbutus Biopharma
ABUS
$841M
$272K 0.07%
56,483
+24,699
XENE icon
287
Xenon Pharmaceuticals
XENE
$5.34B
$271K 0.07%
6,037
+2,568
VERA icon
288
Vera Therapeutics
VERA
$2.75B
$271K 0.07%
5,342
+290
CTMX icon
289
CytomX Therapeutics
CTMX
$795M
$270K 0.07%
+63,491
LXEO icon
290
Lexeo Therapeutics
LXEO
$411M
$270K 0.07%
+27,230
IDYA icon
291
IDEAYA Biosciences
IDYA
$2.48B
$270K 0.07%
7,819
+2,712
DYN icon
292
Dyne Therapeutics
DYN
$2.9B
$270K 0.07%
13,806
+5,937
CYTK icon
293
Cytokinetics
CYTK
$10.4B
$270K 0.07%
4,247
+819
CGON icon
294
CG Oncology
CGON
$5.95B
$270K 0.07%
6,497
+2,203
PROK icon
295
ProKidney
PROK
$230M
$270K 0.07%
+120,376
BEAM icon
296
Beam Therapeutics
BEAM
$2.96B
$270K 0.07%
9,724
+3,200
ANNX icon
297
Annexon
ANNX
$836M
$269K 0.07%
53,527
+11,540
RVMD icon
298
Revolution Medicines
RVMD
$31B
$269K 0.07%
3,371
+603
ORKA
299
Oruka Therapeutics
ORKA
$3.76B
$267K 0.07%
+8,814
RAPP
300
Rapport Therapeutics
RAPP
$1.77B
$267K 0.07%
8,789
-1,425
10 11
12
13 14